The pan-deacetylase inhibitor panobinostat affects angiogenesis in hepatocellular carcinoma models via modulation of CTGF expression

By                          

International Journal of Oncology, Vol. 47, Iss. 3, 2015-01 ,pp. : 963-970

Spandidos Publications

Access to resources Recommend Favorite

Epithelial––mesenchymal transition in hepatocellular carcinoma

By van Zijl Franziska   Zulehner Gudrun   Petz Michaela   Schneller Doris   Kornauth Christoph   Hau Mara   Machat Georg   Grubinger Markus   Huber Heidemarie   Mikulits Wolfgang  

Future Oncology, Vol. 5, Iss. 8, 2009-10 ,pp. : 1169-1179

Future Medicine

Access to resources Recommend Favorite

Panobinostat (LBH589): a potent pan-deacetylase inhibitor with promising activity against hematologic and solid tumors

By Prince H Miles   Bishton Mark J   Johnstone Ricky W  

Future Oncology, Vol. 5, Iss. 5, 2009-06 ,pp. : 601-612

Future Medicine

Access to resources Recommend Favorite

Cordycepin Suppresses Integrin/FAK Signaling and Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 1, 2014-01 ,pp. : 29-34

Bentham Science Publishers

Access to resources Recommend Favorite

Epithelial-mesenchymal transition expression profiles as a prognostic factor for disease-free survival in hepatocellular carcinoma: Clinical significance of transforming growth factor-β signaling

By                  

Oncology Letters, Vol. 5, Iss. 1, 2013-01 ,pp. : 149-154

Spandidos Publications

Access to resources Recommend Favorite